These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 39383403)

  • 1. Advances in the development of new vaccines for tuberculosis and Brazil's role in the effort forward the end TB strategy.
    Junqueira-Kipnis AP; Leite LCC; Croda J; Chimara E; Carvalho ACC; Arcêncio RA
    Mem Inst Oswaldo Cruz; 2024; 119():e240093. PubMed ID: 39383403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research Advances for Virus-vectored Tuberculosis Vaccines and Latest Findings on Tuberculosis Vaccine Development.
    Hu Z; Lu SH; Lowrie DB; Fan XY
    Front Immunol; 2022; 13():895020. PubMed ID: 35812383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards building a tuberculosis free world.
    Mandal S
    Indian J Tuberc; 2022 Jul; 69(3):259-261. PubMed ID: 35760473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of the COVID-19 pandemic on TB diagnosis in the Brazilian prison population, 2020-2021.
    do Nascimento DR; Serpa SF; Bezerra-Santos M; do Carmo RF; de Brito RJVC; Gomes OV; da Costa Armstrong A; de Souza CDF
    Int J Tuberc Lung Dis; 2023 Sep; 27(9):688-693. PubMed ID: 37608478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine development against tuberculosis before and after Covid-19.
    Kaufmann SHE
    Front Immunol; 2023; 14():1273938. PubMed ID: 38035095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculosis vaccines update: Is an RNA-based vaccine feasible for tuberculosis?
    Larsen SE; Baldwin SL; Coler RN
    Int J Infect Dis; 2023 May; 130 Suppl 1():S47-S51. PubMed ID: 36963657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. End-point definition and trial design to advance tuberculosis vaccine development.
    Garcia-Basteiro AL; White RG; Tait D; Schmidt AC; Rangaka MX; Quaife M; Nemes E; Mogg R; Hill PC; Harris RC; Hanekom WA; Frick M; Fiore-Gartland A; Evans T; Dagnew AF; Churchyard G; Cobelens F; Behr MA; Hatherill M
    Eur Respir Rev; 2022 Jun; 31(164):. PubMed ID: 35675923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Latest advances in the development of tuberculosis vaccines in global clinical trials: a review].
    Zhou F; Zhang Y; Zhang D
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2024 Mar; 36(2):201-206. PubMed ID: 38857967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meeting report: Virtual Global Forum on Tuberculosis Vaccines, 20-22 April 2021.
    Suliman S; Pelzer PT; Shaku M; Rozot V; Mendelsohn SC
    Vaccine; 2021 Dec; 39(50):7223-7229. PubMed ID: 34538522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives on development and advancement of new tuberculosis vaccines.
    da Costa C; Benn CS; Nyirenda T; Mpabalwani E; Grewal HMS; Ahmed R; Kapata N; Nyasulu PS; Maeurer M; Hui DS; Goletti D; Zumla A
    Int J Infect Dis; 2024 Apr; 141S():106987. PubMed ID: 38417616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How could we have better vaccines against tuberculosis?
    Giri PK
    Expert Opin Biol Ther; 2008 Nov; 8(11):1759-72. PubMed ID: 18847310
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Jia Q; Masleša-Galić S; Nava S; Horwitz MA
    mBio; 2022 Jun; 13(3):e0068722. PubMed ID: 35642945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in protein subunit vaccines against tuberculosis.
    Zhang Y; Xu JC; Hu ZD; Fan XY
    Front Immunol; 2023; 14():1238586. PubMed ID: 37654500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unsuccessful tuberculosis treatment outcomes across Brazil's geographical landscape before and during the COVID-19 pandemic: are we truly advancing toward the sustainable development/end TB goal?
    Tavares RBV; Berra TZ; Alves YM; Popolin MAP; Ramos ACV; Tártaro AF; de Souza CF; Arcêncio RA
    Infect Dis Poverty; 2024 Feb; 13(1):17. PubMed ID: 38369536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide-Based Vaccines for Tuberculosis.
    Gong W; Pan C; Cheng P; Wang J; Zhao G; Wu X
    Front Immunol; 2022; 13():830497. PubMed ID: 35173740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Model-based impact evaluation of new tuberculosis vaccines in aging populations under different modeling scenarios: the case of China.
    Tovar M; Sanz J; Moreno Y
    Front Public Health; 2024; 12():1302688. PubMed ID: 38463158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculosis vaccine: A journey from BCG to present.
    Fatima S; Kumari A; Das G; Dwivedi VP
    Life Sci; 2020 Jul; 252():117594. PubMed ID: 32305522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel vaccine candidates against Mycobacterium tuberculosis.
    Khoshnood S; Heidary M; Haeili M; Drancourt M; Darban-Sarokhalil D; Nasiri MJ; Lohrasbi V
    Int J Biol Macromol; 2018 Dec; 120(Pt A):180-188. PubMed ID: 30098365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The COVID-19 and TB syndemic: the way forward.
    Trajman A; Felker I; Alves LC; Coutinho I; Osman M; Meehan SA; Singh UB; Schwartz Y
    Int J Tuberc Lung Dis; 2022 Aug; 26(8):710-719. PubMed ID: 35898126
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.